NCT06948552
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
- Locations
-
- Henry Ford Hospital Detroit, Michigan, United States
Clinical trial condition
Upper Tract Urothelial Carcinoma
Explore clinical trials studying Upper Tract Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.
16 public trials
9 recruiting studies
Upper Tract Urothelial Carcinoma trial results
Recruiting
Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
NCT07614594
- Conditions
- Bladder Cancer (BC), Carcinoma, Carcinoma, Transitional Cell, +19 more
- Locations
-
- Henan Provincial People's Hospital Zhengzhou, Henan, China
NCT07321210
- Conditions
- Lymph Node Dissection, Upper Tract Urothelial Carcinoma
- Locations
-
- Tianjin Medical University Second Hospital Tianjin, Tianjin Municipality, China
NCT07492628
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT06040762
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07225374
- Conditions
- Upper Tract Urothelial Carcinoma
- Locations
-
- Samsung Medical Center Seoul, Gangnam, South Korea
NCT06848868
- Conditions
- Upper Tract Urothelial Carcinoma
- Locations
-
- Prince of Wales Hospital Hong Kong
- The Chinese University of Hong Kong Hong Kong
NCT07126119
- Conditions
- Nab-paclitaxel, Neoadjuvant Therapy, PD-1 Inhibitor, +1 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
NCT05917158
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China Nanjing, Jiangsu, China
Not Yet Recruiting
Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper Tract Urothelial Carcinoma
NCT07584733
- Conditions
- Upper Tract Urothelial Carcinoma
- Locations
-
- Ethics Committee of Shanghai Renji Hospital Shanghai, Shanghai Municipality, China